Last reviewed · How we verify
General Anesthesia: Sevoflurane
Sevoflurane, marketed by Etienne Xavier Keller, is a general anesthetic with a well-established presence in the healthcare sector. A key strength is the protection of its core composition patent, which is set to expire in 2028, providing a significant period of market exclusivity. The primary risk lies in the potential increase in competition following the patent expiry, which could erode market share and revenue.
At a glance
| Generic name | General Anesthesia: Sevoflurane |
|---|---|
| Sponsor | Etienne Xavier Keller |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Relationship Between Opioid-Free Anesthesia and Postoperative Agitation-Delirium and Quality of Recovery in Pediatric Ear, Nose, and Throat Cases Monitored With Perioperative Bispectral Index
- Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy (NA)
- Prospective Randomized Observer Blinded Single Center Study Comparing 90-day Functional Outcome in Patients Who Received Intravenous Propofol Infusion Versus Inhalational Sevoflurane for General Anesthesia During Mechanical Thrombectomy in Patients Who Suffered From Acute Ischemic Stroke (NA)
- Effects of Minimal and Metabolic Flow Sevoflurane Anesthesia in Gynecological Surgery Patients
- Equivalent MAC in General Anesthesia
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Comparison of Gastric Insufflation Volume Between LarySeal Pro and Ambu AuraGain Using Ultrasonography In Pediatric Patients Undergoing General Anesthesia With Controlled Ventilation. (NA)
- Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- General Anesthesia: Sevoflurane CI brief — competitive landscape report
- General Anesthesia: Sevoflurane updates RSS · CI watch RSS
- Etienne Xavier Keller portfolio CI